FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a combination tablet containing lansoprazole, amoxicillin, and clarithromycin (Rising Pharma Holdings, Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Lansoprazole (Lansoprazole)
• clarithromycin (clarithromycin)

Snippet

SUPPL AP for LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN (LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN)